News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Acambis PLC Release: Results For The Three And Nine Months Ended 30 September 2006
November 9, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Cambridge, UK and Cambridge, Massachusetts – 7 November 2006 – Acambis plc (Acambis or the Company) (LSE: ACM, NASDAQ: ACAM) announces its results for the three and nine months ended 30 September 2006.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Manufacturing
PharmaEssentia Shores up Supply with $46M Investment in Puerto Rico Plant
February 11, 2026
·
2 min read
·
Nick Paul Taylor
Earnings
Gilead To Stay ‘Proactive And Disciplined’ With Deals But M&A Not Urgent Priority
February 11, 2026
·
2 min read
·
Tristan Manalac
Podcast
Weight Loss Drama Compounds on Heels of Novo, Lilly Earnings, Plus Gene Therapy News
February 11, 2026
·
1 min read
·
Jef Akst
Earnings
AstraZeneca Teases ‘Very Competitive’ Weight-Loss Pill—But Stays Mum on Details
February 10, 2026
·
2 min read
·
Tristan Manalac
